Bone Strength + Bone Mineral Density Screening Cost-Effective

This article originally appeared here.
Share this content:
Bone Strength + Bone Mineral Density Screening Cost-Effective
Bone Strength + Bone Mineral Density Screening Cost-Effective

FRIDAY, Oct. 27, 2017 (HealthDay News) -- Combined assessment of bone strength and bone mineral density is a cost-effective strategy for osteoporosis screening in postmenopausal women, according to a study published in the November issue of Radiology.

Christoph A. Agten, M.D., from the NYU Langone Medical Center in New York City, and colleagues created a model to investigate whether assessment of bone strength with quantitative computed tomography (CT) in combination with dual-energy x-ray absorptiometry (DXA) is cost-effective as a screening tool for osteoporosis in postmenopausal women (≥55 years).

The researchers found that the most cost-effective strategy was combined DXA and quantitative CT screening starting at age 55 with quantitative CT screening every five years (incremental cost-effectiveness ratio, $2,000 per quality-adjusted life year). With this strategy, 12.8 percent of postmenopausal women sustained hip fractures in their remaining life versus 18.7 percent with no screening and 15.8 percent with DXA screening. Vertebral fractures would happen in 7.5, 11.1, and 9 percent, respectively, while wrist fractures were predicted in 14, 17.8, and 16.4 percent, respectively. DXA and quantitative CT at age 55 years with quantitative CT screening every five years was the best strategy in more than 90 percent of the 1,000 simulations.

"Combined assessment of bone strength and bone mineral density is a cost-effective strategy for osteoporosis screening in postmenopausal women and has the potential to prevent a substantial number of fragility fractures," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

California Lawsuit Claims AbbVie Paid Doctors to Prescribe Humira

California Lawsuit Claims AbbVie Paid Doctors to Prescribe ...

Claims physicians prescribed Humira because of financial kickbacks, not as best drug for patient

Patient-Directed IV Remifentanil Cuts Epidural Conversions

Patient-Directed IV Remifentanil Cuts Epidural Conversions

Patient-controlled remifentanil reduces proportion of conversions versus intramuscular pethidine

Pediatricians Have Role in Supporting Transgender Youth

Pediatricians Have Role in Supporting Transgender Youth

Recommendations developed for comprehensive care for youth identifying as transgender, gender diverse

is free, fast, and customized just for you!




Already a member?

Sign In Now »